The latest in health it & security: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: From Automation to Agency: Rethinking the Future of Healthcare.
From Automation to Agency: Rethinking the Future of Healthcare
For years, healthcare provider organizations have pursued automation to improve revenue cycle efficiency. Rules-based workflows, robotic process automation, predictive analytics, and machine learning have each helped reduce manual intervention and accelerate the completion of repetitive tasks. But reimbursement for specialty healthcare services, such as laboratory, radiology, pathology, and spe…
Senators Investigate Insurers’ Role in Removing Thousands from ACA Coverage
Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ coverage over suspected fraud. The post Senators Investigate Insurers’ Role in Removing Thousands from ACA Coverage appeared first on MedCity News.
Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial
Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults with type 2 diabetes. Retatrutide is a peptide designed to activate three metabolic targets versus just one hit by Ozempic. The post Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial appeared first on MedCity News.
Boston Scientific cuts 2026 guidance for third time this year
The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts once again.
Follow the full firehose on the HTC Wire, refreshed automatically every day.